The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 3,361 | 49,756 | SH | SOLE | 49,756 | 0 | 0 | ||
ACADIA HEALTHCARE CO INC | COM | 00404A109 | 5,246 | 128,240 | SH | SOLE | 128,240 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 1,095 | 22,558 | SH | SOLE | 22,558 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 2,064 | 132,160 | SH | SOLE | 132,160 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 2,893 | 40,718 | SH | SOLE | 40,718 | 0 | 0 | ||
BIO-RAD LABRATORIES | COM | 090572207 | 1,708 | 5,918 | SH | SOLE | 5,918 | 0 | 0 | ||
CENTENE CORP | COM | 15135B101 | 4,812 | 39,058 | SH | SOLE | 39,058 | 0 | 0 | ||
DURECT CORPORATION | COM | 266605104 | 1,074 | 688,446 | SH | SOLE | 688,446 | 0 | 0 | ||
ENDOCYTE | COM | 29269A102 | 1,424 | 103,159 | SH | SOLE | 103,159 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 5,078 | 84,937 | SH | SOLE | 84,937 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS INC | COM | 37890U108 | 2,231 | 49,355 | SH | SOLE | 49,355 | 0 | 0 | ||
HERON THERAPEUTICS | COM | 427746102 | 2,583 | 66,488 | SH | SOLE | 66,488 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 466 | 19,695 | SH | SOLE | 19,695 | 0 | 0 | ||
INSMED INC | COM | 457669307 | 4,702 | 198,801 | SH | SOLE | 198,801 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 2,175 | 25,918 | SH | SOLE | 25,918 | 0 | 0 | ||
JAZZ PHARMACEUTICALS | COM | G50871105 | 5,104 | 29,625 | SH | SOLE | 29,625 | 0 | 0 | ||
KADMON HOLDINGS INC | COM | 48283N106 | 1,442 | 361,517 | SH | SOLE | 361,517 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 2,644 | 26,910 | SH | SOLE | 26,910 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 2,237 | 118,869 | SH | SOLE | 118,869 | 0 | 0 | ||
NEURONETICS INC | COM | 64131A105 | 958 | 36,000 | SH | SOLE | 36,000 | 0 | 0 | ||
NUCANA PLC-ADR | ADR | 67022C106 | 910 | 47,872 | SH | SOLE | 47,872 | 0 | 0 | ||
OPKO HEALTH INC | COM | 68375N103 | 1,911 | 406,526 | SH | SOLE | 406,526 | 0 | 0 | ||
OPTINOSE INC | COM | 68404V100 | 9,396 | 335,826 | SH | SOLE | 335,826 | 0 | 0 | ||
PERRIGO CO PLC | COM | G97822103 | 1,705 | 23,389 | SH | SOLE | 23,389 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 3,290 | 87,116 | SH | SOLE | 87,116 | 0 | 0 | ||
PTC THERAPEUTICS | COM | 69366J200 | 6,916 | 205,031 | SH | SOLE | 205,031 | 0 | 0 | ||
QUEST DIAGNOSTICS | COM | 74834L100 | 2,702 | 24,575 | SH | SOLE | 24,575 | 0 | 0 | ||
REGENXBIO INC | COM | 75901B107 | 1,198 | 16,692 | SH | SOLE | 16,692 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 1,487 | 11,249 | SH | SOLE | 11,249 | 0 | 0 | ||
SENSEONICS HOLDINGS INC | COM | 81727U105 | 595 | 144,743 | SH | SOLE | 144,743 | 0 | 0 | ||
SIENNA BIOPHARMACEUTICALS INC | COM | 82622H108 | 372 | 24,516 | SH | SOLE | 24,516 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 3,546 | 14,452 | SH | SOLE | 14,452 | 0 | 0 | ||
VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 1,184 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 9,043 | 53,208 | SH | SOLE | 53,208 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 2,703 | 390,568 | SH | SOLE | 390,568 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 1,463 | 154,207 | SH | SOLE | 154,207 | 0 | 0 |